FIELD: medicine, infectious diseases. SUBSTANCE: invention proposes the use of human interleukin-2 prepared from yeast Saccharomyces cerevisiae. Strain is deposited in All-Russian Collection of industrial microorganisms at N VKPM-U 791. Interleukin-2 is administrated at doses from 100 000 to 3 000 000 IU/24 h/1 m2 patient body surface. In contrast to other interleukins used for treatment of sepsis the proposed interleukin-2 shows stimulating effect on "resting" lymphocytes, induces production of interleukin-8 and tumor necrosis factor. Method can be used for treatment of severe states in human caused by infection and for correction of IMMUNOSUPPRESSION at sepsis in human also. EFFECT: enhanced effectiveness of treatment. 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF LINGERING RELAPSING FORMS OF TUBERCULOSIS AND ITS SPECIFIC COMPLICATIONS IN CHILDREN | 2000 |
|
RU2189249C2 |
| METHOD FOR TREATING MULTIPLE SCLEROSIS | 2001 |
|
RU2199339C2 |
| INTERLEUKIN-2-BASE PHARMACEUTICAL PREPARATION (VARIANTS) | 1998 |
|
RU2140283C1 |
| METHOD OF TREATING SECONDARY IMMUNE DEFICIENCY IN SEPSIS AND SEPTIC SHOCK IN UROLOGY | 2014 |
|
RU2586243C1 |
| IMMUNOSTIMULATING AGENT AND A PREPARATION BASED ON THEREOF | 1995 |
|
RU2120298C1 |
| EARLY DIAGNOSIS METHOD AND SUBSTANCE FOR DETERMINING MALIGNANT TUMORS AND TISSUES | 1997 |
|
RU2130775C1 |
| METHOD FOR ADMINISTERING POSTOPERATIVE INTENSIVE CARE OF GENERALIZED PERITONITIS PATIENTS | 2003 |
|
RU2228193C1 |
| IMMUNOMODULATING PREPARATION "BETALEUKIN" | 1998 |
|
RU2128706C1 |
| PREVENTIVE METHOD OF SUPPURATIVE-SEPTIC COMPLICATIONS CASUED BY SEVERE COMBINED INJURY | 2006 |
|
RU2326687C1 |
| METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
